The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Avdeev S.N.

Sechenov First Moscow State Medical University

Nevzorova D.V.

Sechenov First Moscow State Medical University

Avxentyeva M.V.

Centre for Expertise and Quality Control of Healthcare

Larin E.S.

Research Institute of Healthcare Organization and Medical Management

Komarov A.N.

National Center for Social Support and Rehabilitation Technologies “Doverie”

Krysanov I.S.

Russian University of Medicine

Bykov A.O.

Pirogov Russian National Research Medical University

Nuralieva G.S.

Sechenov First Moscow State Medical University

Pervozvanskiy B.E.

Centre for Outpatient Medical Technologies and Home-Based Medical Care

Tkachenko V.V.

Centre for Outpatient Medical Technologies and Home-Based Medical Care

Krokhin K.A.

Sechenov First Moscow State Medical University

Costs of home-based respiratory support and oxygen therapy

Authors:

Avdeev S.N., Nevzorova D.V., Avxentyeva M.V., Larin E.S., Komarov A.N., Krysanov I.S., Bykov A.O., Nuralieva G.S., Pervozvanskiy B.E., Tkachenko V.V., Krokhin K.A.

More about the authors

Journal: Medical Technologies. Assessment and Choice. 2025;47(3): 93‑102

DOI: 10.17116/medtech20254703193

Read: 313 times

Buy for 300₽
Contact the author
Table of contents

COSTS OF HOME-BASED RESPIRATORY SUPPORT AND OXYGEN THERAPY
COSTS OF HOME-BASED RESPIRATORY SUPPORT AND OXYGEN THERAPY

To cite this article:

Avdeev SN, Nevzorova DV, Avxentyeva MV, et al. . Costs of home-based respiratory support and oxygen therapy. Medical Technologies. Assessment and Choice. 2025;47(3):93‑102. (In Russ.)
https://doi.org/10.17116/medtech20254703193

 
Подписка 2026 Медицинские технологии. Оценка и выбор (Medical Technologies. Assessment and Choice)
МСФ на ЯМ
Использование инфографики авторами научных работ
Recommended articles:
Open obse­rvational study with a retrospective analysis of the effi­cacy and tole­rability of aceclofenac in patients with acute non-specific low back pain. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):99-105
On the issue of choosing anesthesia methods: a comparison of gene­ral medi­cine and clinical dentistry. Stomatology. 2025;(1):76-80
Comparing the effi­cacy of divo­zilimab and second-line treatments for rela­psing-remitting multiple scle­rosis in the Russian Fede­ration: a systematic review and network meta-analysis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):58-68
Effi­cacy and safety of fonturacetam in asthenia: a systematic review and meta-analysis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):69-79
Expe­rience of using ribo­ciclib in the therapy of meta­static breast cancer in a regional onco­logical dispensary. P.A. Herzen Journal of Onco­logy. 2025;(3):89-93
Resu­lts of manual therapy in dege­nerative spine diseases with and without radi­culopathy. (Literature review). Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(4):47-55
Effe­ctiveness and tole­rability of agomelatine (Valdoxan) in the treatment of depression after COVID-19 (TELESFOR study). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):90-98
Abstract:

OBJECTIVE

To assess the direct costs associated with home-based respiratory support and oxygen therapy (RSOT).

MATERIAL AND METHODS

The study included two stages: prospective follow-up of patients receiving home-based RSOT and economic analysis of results. There were 98 patients (mean age 61 years, 56.9% men) divided into 3 groups depending on home-based RSOT: invasive mechanical ventilation (IMV) — 8 (8.2%), non-invasive ventilation (NIV) — 43 (43.9%) and long-term oxygen therapy (LTOT) — 47 (47.9%). Direct costs of home-based RSOT were estimated.

RESULTS

The weighted average monthly expenses per patient with chronic respiratory failure (CRF) requiring RSOT at home were RUR 115.046 (95% CI: RUR 120.374 — 109.717) for IMV, RUR 39.905 (95% CI: RUR 44.336 — RUR 35.473) for NIV and RUR 10.518 (95% CI: RUR 11.128 — RUR 9.909) for LTOT. Most of these costs were related to provision of necessary equipment.

CONCLUSION

Direct costs for home-based RSOT decrease sequentially from IMV to NIV and LTOT.

Keywords:

home-based respiratory support and oxygen therapy
long-term oxygen therapy
non-invasive ventilation
invasive mechanical ventilation
effectiveness
costs analysis

Authors:

Avdeev S.N.

Sechenov First Moscow State Medical University

Nevzorova D.V.

Sechenov First Moscow State Medical University

Avxentyeva M.V.

Centre for Expertise and Quality Control of Healthcare

Larin E.S.

Research Institute of Healthcare Organization and Medical Management

Komarov A.N.

National Center for Social Support and Rehabilitation Technologies “Doverie”

Krysanov I.S.

Russian University of Medicine

Bykov A.O.

Pirogov Russian National Research Medical University

Nuralieva G.S.

Sechenov First Moscow State Medical University

Pervozvanskiy B.E.

Centre for Outpatient Medical Technologies and Home-Based Medical Care

Tkachenko V.V.

Centre for Outpatient Medical Technologies and Home-Based Medical Care

Krokhin K.A.

Sechenov First Moscow State Medical University

Received:

12.06.2025

Accepted:

30.06.2025

Close metadata

References:

  1. Pul`monologiya. Nacional`noe rukovodstvo. Kratkoe izdanie. Pod red. AG Chuchalina. M.: GEOTAR-Media; 2020. (In Russ.).
  2. Avdeev SN. Prakticheskoe rukovodstvo po boleznyam organov dy`haniya. M.: Remedium; 2023. (In Russ.).
  3. Murphy PB, Rehal S, Arbane G, Bourke S, Calverley PMA, Crook AM, et al. Effect of Home Noninvasive Ventilation with Oxygen Therapy vs Oxygen Therapy Alone on Hospital Readmission or Death after an Acute COPD Exacerbation: A Randomized Clinical Trial. JAMA. 2017;317(21):2177-2186. https://doi.org/10.1001/jama.2017.4451
  4. Windisch W. Quality of life in home mechanical ventilation study group. Impact of home mechanical ventilation on health-related quality of life. European Respiratory Journal. 2008;32(5):1328-1336. https://doi.org/10.1183/09031936.00066407
  5. Duiverman ML, Vonk JM, Bladder GB, van Melle JP, Nieuwenhuis J, Hazenberg A, et al. Home initiation of chronic non-invasive ventilation in COPD patients with chronic hypercapnic respiratory failure: a randomised controlled trial. Thorax. 2020;75(3):244-252.  https://doi.org/10.1136/thoraxjnl-2019-213303
  6. Cantero C, Adler D, Pasquina P, Uldry C, Egger B, Prella M, et al. Long-Term Noninvasive Ventilation in the Geneva Lake Area: Indications, Prevalence, and Modalities. Chest. 2020;158(1):279-291.  https://doi.org/10.1016/j.chest.2020.02.064
  7. Ribeiro Baptista B, Baptiste A, Granger B, Villemain A, Ohayon R, Rabec C, et al. Growth of home respiratory equipment from 2006 to 2019 and cost control by health policies. Respiratory Medicine and Research. 2022;82:100930. https://doi.org/10.1016/j.resmer.2022.100930
  8. Maquilón C, Antolini M, Valdés N, Andrade M, Canales K, Rabec C, et al. Results of the home mechanical ventilation national program among adults in Chile between 2008 and 2017. BMC Pulmonary Medicine. 2021;21(1):394.  https://doi.org/10.1186/s12890-021-01764-4
  9. Windisch W, Geiseler J, Simon K, Walterspacher S, Dreher M; on behalf of the Guideline Commission. German National Guideline for Treating Chronic Respiratory Failure with Invasive and Non-Invasive Ventilation: Revised Edition 2017: Part 2. Respiration. 2018;96(2):171-203.  https://doi.org/10.1159/000488667
  10. Calverley PMA. Home economics for COPD care. Respirology. 2020;25(2):124-125.  https://doi.org/10.1111/resp.13762
  11. Avksent`eva MV, Savva NN, Czarenko SV, Kumirova EV. Economic feasibility of long-term home mechanical ventilation in children’s palliative care. Palliativnaya medicina i reabilitaciya. 2016;(2):40-49. (In Russ.).
  12. Gomon YuM, Titova ON, Kolbin AS, Kuzubova NA, Balykina YuE. Economic efficiency of long-term oxygen therapy in patients with chronic lung diseases and severe chronic hypoxemia. RMZh. Medicinskoe obozrenie. 2023;7(8):475-481. (In Russ.). https://doi.org/10.32364/2587-6821-2023-7-8-1
  13. Avdeev SN, Nevzorova DV, Karakulina EV, Avxentyeva MV, Tkachenko VV. Regulation and funding for home respiratory support and oxygen therapy strengthening the capacity. Medical Technologies. Assessment and Choice. 2022;44(3):41-48. (In Russ.). https://doi.org/10.17116/medtech20224403141
  14. Avdeev SN, Nevzorova DN, Ivanova GE, Lebedev GS, Suponeva NA, Avxentyeva MV, et al. Respiratory support and oxygen therapy at home: Clinical results of the prospective observatory study. Meditsinskiy sovet. 2024;(20):70-81. (In Russ.). https://doi.org/10.21518/ms2024-419
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.